Why the study?
Does the combination of dopamine and isosorbide dinitrate improve haemodynamic parameters compared to either agent alone in patients with chronic congestive cardiac failure?
Does the combination of dopamine and isosorbide dinitrate improve haemodynamic parameters compared to either agent alone in patients with chronic congestive cardiac failure?
The addition of sublingual isosorbide dinitrate to dopamine infusion in chronic congestive heart failure enhances cardiac performance while maintaining a lower left ventricular filling pressure compared to dopamine alone.
May improve hemodynamics in chronic HF; single-case observation leaves open need for controlled trials.
The haemodynamic effects of dopamine and isosorbide dinitrate alone and in combination were studied in 8 patients with chronic congestive cardiac failure. In 7 patients dopamine, 6,tg/kg per min, increased mean cardiac index from 2-0 to 3 0 1/min per m2 (P < 0.0005); mean stroke volume index from 20 to 27 ml/m2 (P < 0.0025), and mean left ventricular stroke work index from 14 to 20 g M/M2 (P < 0.0025). Mean left ventricular filling pressure did not change significantly. Isosorbide, 5 to 10 mg sublingually, reduced mean left ventricular filling pressure from 29 to 24 mmHg (P < 0.0005) and mean arterial pressure from 80 to 73 mmHg (P < 0 01), with no significant change in mean cardiac index, stroke volume index, or left ventricular stroke work index. When dopamine was reinfused after isosorbide administration mean cardiac index increased to 3 2 1/min per m2, stroke volume index to 31 mu/m2 (P < 0 05 vs dopamine alone), and left ventricular stroke work index to 23 g in/m2 (P < 0-0125 vs dopamine alone). Mean left ventricular filling pressure rose slightly to 25 mmHg but this was significantly less than for dopamine alone (P < 0 0005). In an eighth patient, whose left ventri- cular filling pressure fell to 12 mmHg after isosorbide, the reinfusion of dopamine was associated with severe bradycardia and hypotension, which responded to the intravenous administration of atropine.
No takes yet. Share an insight, caveat, or question.
Stephens et al. (1978) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: